Targeting Metastases

To prevent cancer recurrence and progression after primary tumour therapy.

Product Development

News

Aug 26, 2022–Board member Lars Hedbys takes over as acting CEO of RhoVac on 1 September (regulatory)Aug 09, 2022–The board decides on first partial repayment of convertible loan (regulatory)Jul 15, 2022–RhoVac's CEO, Anders Månsson, has tendered his resignation (regulatory)

BioStock interview, 2022-05-30 (in Swedish)

Please accept marketing-cookies to watch this video.